Navigation Links
Cheetah Medical's NICOM(R) System for Noninvasive Hemodynamic Monitoring Found to be an Effective Tool for Identification of Acute Heart Failure in the Emergency Department

Cheetah Medical's NICOM(R) System for Noninvasive Hemodynamic Monitoring Found to be... -- TEL AVIV, Israel, November 4, 2010 /PRNewswire/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, New Products & Services, FDA Approval Click to view news release full screen  

Cheetah Medical's NICOM(R) System for Noninvasive Hemodynamic Monitoring Found to be an Effective Tool for Identification of Acute Heart Failure in the Emergency Department


Cleveland Clinic Researchers Find That NICOM (R) Technology Provides a Quick Noninvasive Tool to Help Diagnose Acute Heart Failure in Patients Presenting to the Emergency Department With Shortness of Breath

TEL AVIV, Israel, November 4, 2010 /PRNewswire/ -- A study performed by investigators from the Emergency Department of the Cleveland Clinic Foundation finds that Cheetah Medical's NICOM system is effective in identification of acute heart failure (AHF) and in differentiating it from other acute situations with similar clinical presentations. The study was published last week in the American Journal of Emergency Medicine.

Heart failure exacerbation is a potentially life-threatening condition which frequently manifests as shortness of breath, or "dyspnea." In 2006, over 3 million visits to hospital emergency departments were for a chief complaint of shortness of breath. In addition to heart failure, shortness of breath is associated with a variety of other diagnoses involving the lungs, heart and other organs, including chronic obstructive pulmonary disease (COPD), asthma, metabolic and psychiatric conditions. Early, correct diagnosis and management is key to improve outcomes while relieving heavy patient burdens in hospital emergency departments.

In this study, the Cheetah Medical NICOM(R) Noninvasive Cardiac Output & Hemodynamic Monitoring System was able to distinguish heart failure patients from patients diagnosed with COPD, asthma and dyspnea for other reasons. This US FDA-cleared, fully non-invasive bedside test utilizes a set of four sensors applied on the patient's chest or back. In this study, the system was used to monitor patients' hemodynamics around a change in patient position, also known as "orthostatic challenge". The NICOM system captured the markedly different hemodynamic response of heart failure patents as compared to the other causes of dyspnea and to accurately differentiate between heart failure and other conditions.

Rakesh Engineer, MD, FACEP, Discipline Leader, Emergency & Undifferentiated Care at the Cleveland Clinic Lerner College of Medicine and the study's Primary Investigator, said: "Acute heart failure affects 5.8 million Americans per year, with costs exceeding $33 billion. Clinical judgment, even when combined with our best biomarkers, produces a diagnostic accuracy of only 82.5%. Clearly, new methods to determine the etiology of shortness of breath in emergency patients are needed. This study illustrates the utility of NICOM Bioreactance Technology in differentiating acute heart failure from asthma and COPD".

W. Frank Peacock, MD, FACEP, Vice Chair, Emergency Medicine Institute, Cleveland Clinic Foundation, and the study's Senior Author, said: "Outcomes in patients presenting to the emergency department with acute shortness of breath are related to appropriate and timely therapy. When therapy is delayed or inappropriate, the acute mortality rate is increased. Our data suggest that an early and accurate heart failure diagnosis can be determined by measuring hemodynamic changes using NICOM Technology."

About Acute Heart Failure and Its Diagnosis in the Emergency Department

Emergency department (ED) visits for symptoms related to heart failure are very common, responsible for about 5% of annual visits to the ED in the US. Determining the most accurate early diagnosis of heart failure remains a clinical challenge. The best currently available diagnostic laboratory tests and clinical decision-making in the emergency department yield a diagnostic accuracy for acute heart failure of about 80%. Acute heart failure requires rapid diagnosis and management as it is associated with significant near-term mortality and high healthcare costs. There are over one million annual hospital admissions for heart failure in the U.S. alone, with total national hospital costs exceeding $33 billion. Initiating the earliest appropriate treatment protocols for acute heart failure can help to reduce patient morbidity and mortality, as well as reduce healthcare costs.

About Cheetah Medical

Cheetah Medical's NICOM(R) Noninvasive Cardiac Output and Hemodynamic Monitoring System uses the company's proprietary BIOREACTANCE(R) Technology to deliver continuous, accurate, noninvasive cardiac output (CO) and other vital hemodynamic monitoring parameters, useful for fluid management and drug titration. The system is US FDA cleared and CE Marked, and since its commercial launch in 2008 has been adopted by a growing number of clinicians worldwide. Cheetah Medical headquarters is located in Tel-Aviv, Israel and its United States headquarters is located in Portland, Oregon. For more information, visit our website at

For More Information Contact: Yoav Avidor, MD Chief Executive Officer Cheetah Medical Telephone: +972-3-644-0288

SOURCE Cheetah Medical Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cheetah Medical Announces European Launch of a New NICOM(R) System for Advanced Noninvasive Hemodynamic Monitoring and Fluid Management
2. Cheetah Medical Closes $20 Million Series B Financing
3. ECRI Institute Awarded AHRQ Contract to Establish National Healthcare Horizon Scanning System
4. Interventional Spine®, Inc. Announces Issuance of Key Patents for the PERPOS® PLS System
5. Actavis Encourages Consumers to Return Fentanyl Transdermal System 25 mcg/h
6. Medicare Bidding System for Medical Equipment Plagued by Flaws, Delays, Lack of Transparency
7. Saudi Arabias King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy
8. GeNO LLC Submits Investigational New Drug Application for Its NITROsyl™ Inhaled Nitric Oxide System to Treat Chronic Pulmonary Hypertension
9. Varian Medical Systems to Supply Four Advanced Radiotherapy Treatment Machines to Global Hospitals in India
10. CURE Foundation Selects Varian Medical Systems to Supply Radiotherapy Technology for Five New Cancer Centers
11. CyberKnife® VSI™ System Expands Treatment Applications and Significantly Reduces Treatment Times
Post Your Comments:
(Date:10/9/2015)... , Oct. 9, 2015 Eli Lilly and Company ... square feet and approximately 50 new jobs to its research ... New York, New York . ... 2016, this space will include a translational immuno-oncology hub and ... opportunities for collaborative access to cutting-edge drug discovery capabilities, including ...
(Date:10/9/2015)... 9, 2015 Ansun BioPharma announced a presentation ... America ) regarding the compassionate use of DAS181 under ... respirator who was co-infected with influenza and parainfluenza (Abstract ... therapy, O 2 requirement was reduced and the ... to go off the respirator on day 5. Between ...
(Date:10/9/2015)... , Suiza, October 9, 2015 El ,JCA-Mauvernay ... Yutaka Kondo y Junko Takita    ... otorgado a los doctores Yutaka Kondo y ... ,JCA-Mauvernay Award 2015, se ha otorgado a los doctores ...    ™ , una compañía biofarmacéutica global con sede enSuiza, ...
Breaking Medicine Technology:
... NEW YORK, Sept. 12, 2011 A revolutionary new ... other technology - - the VivoSight® Optical Coherence ... to dermatologists in the U.S. for the first time. ... skin surface instantly, providing additional information which will allow ...
... Sept. 12, 2011 Intarcia Therapeutics, Inc. announced ... ITCA 650 (DUROS® subcutaneous continuous delivery of exenatide) ... the 47th Annual Meeting of the European Association ...  All three presentations are scheduled for Wednesday, September ...
Cached Medicine Technology:
(Date:10/10/2015)... ... October 10, 2015 , ... The sixth annual cost ... the growth of cybercrime costs for US companies. The New York Times broke down ... With averages showing increases hovering around 20% among the companies surveyed, it only proves ...
(Date:10/10/2015)... ... October 10, 2015 , ... Story Chaser ... It works by reading various classics and inspiring stories and as words drop down ... , The animations are extremely aesthetic and can be interacted with, making it a ...
(Date:10/10/2015)... ... ... Isabel Healthcare will participate in the Cerner Health Conference October 11-14, 2015 ... Institute of Medicine’s latest report “Improving Diagnosis in Healthcare”, Isabel Healthcare will be featuring ... and consumers to potentially reduce the chance of error. The report suggests that most ...
(Date:10/10/2015)... FLA. (PRWEB) , ... October 10, 2015 , ... In ... has been named the Best Place To Work in Jacksonville, amongst medium-sized companies with ... September 27th and was followed up with a celebratory gala on October 1st. ...
(Date:10/9/2015)... ... October 09, 2015 , ... The American ... Dean for Graduate Medical Education J. Michael Finley, DO, as the recipient of ... selected for his impact on graduate medical education opportunities for osteopathic residents, and ...
Breaking Medicine News(10 mins):
... flu outbreak in February in India, the poultry market saw a ... the government assured the people that all the necessary measures are ... the avian flu the sales of chicken and other birds saw ... deaths due to bird flu the sales dips drastically. Every time ...
... of cognitive behavior therapy (CBT) in overcoming depression can ... the University of Pittsburgh School of Medicine. In a ... Journal of Psychiatry, the official journal of the American ... the response to therapy could be a valuable tool ...
... who suffer from severe urinary infection are more likely ... had found a link between acute infections and heart ... infections and clotting in large veins, reported the online ... at the London School of Hygiene and Tropical Medicine ...
... new genes found with breast tumors can predict the outcomes ... the report appearing in he April 1 issue of Clinical ... women at risk for an early relapse of breast cancer. ... discovered as a potential marker of relapse in hormone-receptor positive ...
... from Sheffield University most women still believe one-night stands ... revealed that women of all ages believe that sex ... ,The women community despite achieving liberation still feels ... of desperation or drunkenness. The research which was followed ...
... are still left confused despite making in-depth analysis in ... psychiatric problem that affects the children. ... which is beyond the scientists' control, between 30 percent ... co-existing conditions, so-called comorbidities that make diagnosis and treatment ...
Cached Medicine News:
... Built on the market leading optical performance ... has been optimized for even better views ... system, including a new XHL Xenon Halogen ... cornea and clear, high resolution images of ...
... 2.2 Fr Sur-Catch NT stone retrieval basket raises ... Its unique paired wire design and multi-sizing ... the needs of each patient and procedure. ... for use with the DURTM-8 Elite Ureteroscope and ...
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
... is a minimally invasive, highly effective surgical ... incontinence. GYNECARE TVT is positioned close to ... and when needed, TVT provides tension-free support ... The procedure takes approximately 20 to 30 ...
Medicine Products: